Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Illumina Names Klausner as SVP, CMO

Premium

Illumina said this week that it has appointed Richard Klausner as senior vice president and chief medical officer.

Prior to joining Illumina, Klausner was managing partner of venture capital firm The Column Group. He has also served as executive director for global health at the Bill and Melinda Gates Foundation, and as the eleventh director of the National Cancer Institute between 1995 and 2001. Klausner has also been chief of cell biology and metabolism at the National Institute of Child Health and Human Development; past president of the American Society of Clinical Investigation; and chairman of the National Science Education Standards Projects of the National Academy of Sciences. He holds an MD from Duke University.


Gregory Lucier has been appointed to the board of directors at RainTree Oncology and elected chairman of the board at Sanford-Burnham Medical Research Institute.

Lucier is CEO and chairman of Life Technologies. He also serves on the boards of CareFusion, Synthetic Genomics, and Rady Children's Hospital. He holds a BS in engineering from Pennsylvania State University and an MBA from Harvard Business School.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.